SREBF1 and metabolic dysfunction-associated steatotic liver disease: PPARγ was up-regulated in the liver of obese patients with NAFLD, which showed positive associations with SREBP-1c mRNA levels or serum insulin levels, reinforcing a lipogenic mechanism to SREBP-1c induction and up-regulating genes that encode for lipogenic proteins in the development of hepatic steatosis [141].